USA Today - 17.10.2019

2A z THURSDAY, OCTOBER 17, 2019 z USA TODAY NEWS

Customer service

To view important information online related to

your subscription, visit aboutyoursubscription.

usatoday.com. You can also manage your

subscription at account.usatoday.com

Contact USA TODAY for questions or to report

issues via email at [email protected] or by

phone at 1-800-872-0001.

Operating hours are:

zMonday-Friday: 8:00 a.m.-7:00 p.m. EST

Available subscriptions

Subscribe and save today by visiting

usatoday.com/subscribe. The subscription below

is billed monthly and includes 24/7 access to

usatoday.com, breaking news on our tablet and

smartphone apps, subscriber benefits at

usatoday.com/memberguide and the eNewspaper,

a digital replica of the print edition.

zDelivery of the Monday through Friday print

editions: $29.

*Plus applicable taxes

Contact us

Customer Service ..............................1-800-872-

Newsroom.......................703-854-3400, ext. 5, ext. 5

Classified advertising......................1-800-397-

National, regional advertising..........703-854-

Corrections and

clarifications

Our goal is to promptly correct

errors. Email us at

[email protected] to report

a mistake

or contact Standards Editor Manny Garcia at 1-800-

872-7073. Describe the error, where you saw it, the

date, page number, or the URL.

Postal information

Volume 38, No. 24

USA TODAY, USPS #684090, ISSN #0734-7456, is

published Monday through Friday at 7950 Jones

Branch Dr. McLean, VA 22108. Periodicals postage

paid at McLean, VA 22108. Postmaster: Send

address changes to Customer Service, PO Box

94090, Albuquerque, NM 87199-

WASHINGTON – A half-dozen Re-
publican lawmakers sought access
Wednesday to a closed-door deposition
with a former State Department official
that is part of the House impeachment
inquiry, but they were blocked in an es-
calation of the partisan dispute over the
investigation of President Donald
Trump.
Three House committees – Foreign
Affairs, Intelligence and Oversight and
Reform – have been meeting privately
for weeks with current and former ad-
ministration officials to gather informa-
tion about how Trump urged Ukraine to
investigate Joe Biden, a political rival.
The latest session Wednesday was with
Michael McKinley, a former senior ad-
viser to Secretary of State Mike Pompeo.
A previous witness, Kurt Volker, a for-
mer special envoy to Ukraine, appeared
Wednesday to review the transcript

from his session Oct. 3.

Republicans have complained that

the meetings should be public and tran-

scripts should be released. Access has

been limited to members of the three

panels. Intelligence Committee Chair-

man Adam Schiff, D-Calif., said private

sessions are needed to prevent witness-

es from hearing each other.

Leading the confrontation was

House Minority Leader Kevin McCar-

thy, R-Calif., who called Schiffa liar and

a partisan leading a witch hunt – lan-

guage that echoes Trump’s terminology.

McCarthy cited Schiff ’s opening state-

ment Sept. 26 in a public hearing with

the acting director of national intelli-

gence, Joseph Maguire,which charac-

terized Trump’s phone call July 25 as a

mafia shakedown.

“I can’t even go down there and read

the transcript,” McCarthy said.

McCarthy alleged that Republicans

have not been allowed to cross-examine

the witnesses, which is not accurate.

Staff attorneys led the questioning, and

the time was evenly divided between

Democratic and Republican aides.

“They designed a process to pick and

choose who to come,” McCarthy said.

Schiffsaid Tuesday that transcripts

would be released and public hearings

held.

Members of the Judiciary Commit-

tee, which traditionally handles im-

peachment inquiries, argued Wednes-

day that they deserve access to the de-

positions and transcripts of sessions.

Rep. Louie Gohmert, R-Texas, said he

was told by the impeachment panel’s

staff that he could not read the tran-

scripts of interviews or attend McKin-

ley’s private session.

“That is garbage,” Gohmert said.

“This is an insane asylum, and it’s clear

the inmates are running it, because the

elected people ... said we want you to

participate.”

Impeachment: GOP complains about lack of access

Lawmakers seek public

meetings, transcripts

Deirdre Shesgreen and Bart Jansen
USA TODAY

House Minority Leader Kevin

McCarthy, R-Calif., says Democrats

have prevented him from accessing

transcripts from the impeachment

inquiry.TASOS KATOPODIS/GETTY IMAGES

Earlier, during an East Room news
conference with Italian President Sergio
Mattarella, Trump welcomed reports
that Russian troops entered regions
once occupied by a small number of U.S.
special operations forces.
“Frankly, if Russia is going to help the
Kurds, that’s a good thing,” Trump said.

‘Not angels’

Trump said one group of Kurds, the
Kurdistan Workers’ Party, is “more of a
terrorist threat” than the Islamic State.
“They’re not angels,” Trump said
Wednesday.
The United States considers the Kur-
distan Workers’ Party, or the PKK, a ter-
rorist organization. U.S. troops allied
with what Turkey described as an off-
shoot of that group, the People’s Protec-

tion Units, or YPG, to fight the Islamic

State in Syria.

“They’ve got a lot of sand over there,”

Trump said. “There’s a lot of sand that

they can play with.”

The president has repeatedly framed

his decision in Syria as part of his broad-

er pledge to withdraw U.S. troops from

foreign entanglements.

It’s not clear how many of the 1,

service members Trump intends to

withdraw from Syria will return to the

USA versus being redeployed to other

countries in the region.

Graham: ‘Outrageously dangerous’

Sen. Lindsey Graham, R-S.C., has

been a close Trump ally on many issues

but critical of the president’s Middle

East policy.

“What the president said today is just

outrageously dangerous,” Graham said.

“It undercuts Pence and Pompeo. And I

don’t agree with his construct that Tur-

key’s invasion of Syria is of no concern.”

Trump noted the senator’s long-held

hawkish foreign policy views.

“Lindsey Graham would like to stay

in the Middle East for the next 1,

years,” Trump said before suggesting

that voters in South Carolina would pre-

fer that their senior senator focuson

other issues, such as getting judges con-

firmed.

More than 90 House Republicans in-

troduced legislation Monday that would

require the president to impose far-

reaching sanctions on Turkey. The legis-

lation, led by Rep. Liz Cheney, R-Wyo.,

seeks to ban U.S. military transactions

with Turkey and would slap economic

penalties on Turkish President Recep

Tayyip Erdogan and other high-ranking

members of his government.

The House voted 354-60 Wednesday

to approve a rare bipartisan rebuke of

Trump’s handling of the situation. Two-

thirds of the Republicans joined with

the Democrats to support the measure.

Contributing: Tom Vanden Brook,

Christal Hayes and Maureen Groppe

Syria

Continued from Page 1A

ADVERTISEMENT

Good News for Americans,Bad News for Pain Drugs

Millions areexpected to benefit fromanew technology that couldrelieve ye arsofs everejoint discomfort;

reprograms the body to block slowburning inflammation instead of creating it

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE. RESULTS MAYVARY.

Veraflex producers are making these new pills as fast as possible

to meet the growing and increasing demand.

Severa lofthe major drug

companies behind popular pain

relievers maytakeafinancial hit as

manufacturing ofanew pill is now

complete.

Usinganew technology,the

pill could be safer and more

effectivethan manystorebought

brands.

The pill,VeraFlex,was devel-

oped in Mayofthis year by a

private companyinSeattle.

Functioning primarily as an im-

mune modulator,the pill targets

the body’simmunesystem which

can decrease pain in the body.

The Science BehindRelief

Research shows that the joint

stiffness,soreness and discom-

fort associated with arthritis is

causedby inflammation which

attacks healthycartilage and

protectivetissue.

And according to leading med-

ical scientists,this inflammation

is causedby twoinflammatory

enzymesreleasedby the body’s

immunesystem.

Remarkably,the activeingre-

dients inVeraFlexhelp to block

the production of both these

enzymes,resulting inadramatic

decreasing in swelling, inflam-

mation, and discomfort.

Right now, the leadingover-

the-counter pills areonly able to

block one of these enzymes!

It’swhy so manysufferersfail

to everfind relief.

YearsofDiscomfort

Relievedin5Days

“VeraFlexuserscan generally

expect moreflexibility in three

days...their joint pain alleviated

in fivedays...and in just seven

days, atremendous improve-

ment in overall joint function

that mayhelp them move like

theydid yearsprior”explains Dr.

Liza Leal, developer and spokes-

person forVeraFlex.

8patents that spread from the

US into Canada. And aswould

one guess,it’sbacked by an

enormous amount of research,

including twopatient clinical

trials.

In the first, 60 participants with

rheumatoid arthritis and/or os-

teoarthritiswere randomly placed

into four groups.

Twogroups weregiven the pat-

ented ingredient inVeraFlex,one

wasgiven the drug Celecoxib,

and the last groupaplacebo. The

resultsweremonitored at30,60,

and 90 days.

The data collectedby re search-

erswas stunning.

The groups taking theVeraFlex

ingredient sawstaggering

improvements in arthritissymp-

toms such as flexibility,discom-

fort and function.

And evenmoreastonishing

theyexperienced adramatic

reduction in painby the 30-day

mark thatwasevenbetter than

Celecoxib,apowerful drug!

Asecond studywasconducted

to ensurethe datawasaccurate

and again theresults participants

experienced taking theVeraFlex

compound blewaway researchers.

This time it beat out the drug

Naproxen. Shockingly,both

men andwomenexperienced a

reduction in joint stiffness two

days faster than when using

Naproxen.

“I have to admit Iwas sur-

prised when Iread the initial

findings” explains Leal. “But

whenyoulook at the science it

just makes sense.It’sgoing to

changeeverything.”

Faster Delivery,Maximum

Absorption

VeraFlexis mainly comprised

of twopatented ingredients:

Univestin, apowerful immune

modulator which blocks the

enzymes which causeyour joints

to hurt and BiAloe,anabsorp-

tion enhancer (accelerator) that

ensures maximum potency.

Research shows that severe

joint discomfort arises when the

immune system goes haywire

and releases COXand LOXinto

your blood stream, twoenzymes

that causes tremendous swell-

ing and inflammation around

cartilage and protectivetissue.

Over time,this inflammation

overwhelms the joint and it

begins to deteriorateresulting in

adaily battle with chronic pain.

Unfortunately,modern day

pain pills areonly able block

only one of these enzymes,

resulting in marginalrelief and

continued suffering.

The Univestin in VeraFlex

is one of the only known sub-

stances which has been proven

successful in blocking both en-

zymes,resulting in phenomenal

relief from thewors tkinds of

discomfort.

The addition of BiAloe,a

unique aloevera extra, maximiz-

es the delivery of the plant based

Univestinextract toevery joint in

the body because it is provento

improve nutrient absorption for

maximumresults.

AloeVera also is provento

support the body’simmune

system which manages inflam-

mation, further supportingrelief.

HowtoClaim aFree

3-Month Supply OfVeraFlex

This is the official nationwide

release ofVeraFlex.And so, the

companyisoffering ourreaders

up to3FREE bottles with their

order.

This special give-away is avail-

able for the next 48-hoursonly.

All youhave to do is call toll free

1-800-235-2623and provide the

operator with the FreeBottle

ApprovalCode: VF350. The

companywill do therest.

Important: Due toVeraFlex’s

recent mediaexposure, and Dr.

Leal’slatest book deal, phone

lines areoften busy. If youcall

and do not immediately get

through, please be patient and

call back. Those who miss the

48-hour deadline maylose out

on this free bottle offer.

“It’sani ncredibly powerful lit-

tle pill. And with the addition of

apatented absorption enhancer,

it packs anevengreater punch.

That’swhy I’m soexcited to be

the first to sharethese results.

It’sgiving suffererstheir life

back.”

ASafer,MoreEffective

Avenue to AmazingRelief

Its widely accepted through

the medical community that

inflammatory enzymes arethe

primary cause of pain and suffer-

ing in millions of Americans.It’s

whymost prescriptions andeven

nonprescription pills aredesigned

to block them.

However, what most people

don’t knowisthat eventhe most

advanced ones can’t block both!

Andyet, that’sexactly what

VeraFlexis designed to do and

whyitworks sowell.

“Top pharma companies have

struggled to createadrug that

blocks COXand LOX; the medical

names for the twoinflammatory

enzymes in the body.Consider

the top seller Celebrex,itonly

blocks onevariation of the COX

enzyme”explains Leal.

“And that’sbecause theyhave

focused on using chemicals in-

stead of natural substances like

VeraFlex.”

“Every VeraFlex capsule

contains an ultra-high dose of a

patented plantextract which has

been clinically shown to block

both enzymes,bringingrelief to

every joint that hurts!

“The kind of relief most

people have neverexperienced.

Ioften saytwo enzymes,twice

the relief. People think I’m kid-

ding until theytry it.”

Piling on the Clinical

Research

Remarkably,the key ingredi-

ent inVeraFlexis protectedby